Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Leonardo Riella, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Leonardo Riella and Anil Chandraker.
Connection Strength

6.028
  1. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch. Transplantation. 2014 Jun 27; 97(12):1247-52.
    View in: PubMed
    Score: 0.597
  2. Jagged2-signaling promotes IL-6-dependent transplant rejection. Eur J Immunol. 2013 Jun; 43(6):1449-58.
    View in: PubMed
    Score: 0.551
  3. Role of the PD-1 pathway in the immune response. Am J Transplant. 2012 Oct; 12(10):2575-87.
    View in: PubMed
    Score: 0.525
  4. Stem cell therapy in kidney transplantation. JAMA. 2012 Jul 11; 308(2):130; author reply 130-1.
    View in: PubMed
    Score: 0.521
  5. Dyslipidemia and its therapeutic challenges in renal transplantation. Am J Transplant. 2012 Aug; 12(8):1975-82.
    View in: PubMed
    Score: 0.515
  6. Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. Am J Transplant. 2012 Apr; 12(4):846-55.
    View in: PubMed
    Score: 0.505
  7. Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy. Am J Kidney Dis. 2011 Apr; 57(4):641-5.
    View in: PubMed
    Score: 0.473
  8. Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation. Transplant Direct. 2019 May; 5(5):e446.
    View in: PubMed
    Score: 0.208
  9. Longitudinal immunological characterization of the first presensitized recipient of a face transplant. JCI Insight. 2017 Jul 06; 2(13).
    View in: PubMed
    Score: 0.184
  10. Acute myeloid leukemia after kidney transplantation: a case report and literature review. J Bras Nefrol. 2016 Dec; 38(4):455-461.
    View in: PubMed
    Score: 0.177
  11. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLoS One. 2016; 11(7):e0158431.
    View in: PubMed
    Score: 0.172
  12. Codominant Role of Interferon-?- and Interleukin-17-Producing T Cells During Rejection in Full Facial Transplant Recipients. Am J Transplant. 2016 07; 16(7):2158-71.
    View in: PubMed
    Score: 0.169
  13. Recombinant PTH therapy for severe hypoparathyroidism after kidney transplantation in pre-transplant parathyroidectomized patients: review of the literature and a case report. Clin Transplant. 2015 Nov; 29(11):951-7.
    View in: PubMed
    Score: 0.163
  14. Salt Accelerates Allograft Rejection through Serum- and Glucocorticoid-Regulated Kinase-1-Dependent Inhibition of Regulatory T Cells. J Am Soc Nephrol. 2015 Oct; 26(10):2341-7.
    View in: PubMed
    Score: 0.157
  15. Beyond calcineurin inhibitors: emerging agents in kidney transplantation. Curr Opin Nephrol Hypertens. 2013 Nov; 22(6):689-97.
    View in: PubMed
    Score: 0.143
  16. Blockade of Notch ligand d1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation. J Immunol. 2011 Nov 01; 187(9):4629-38.
    View in: PubMed
    Score: 0.123
  17. Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts. Am J Transplant. 2011 Apr; 11(4):832-40.
    View in: PubMed
    Score: 0.119
  18. Animal models of chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction. Transplantation. 2010 Nov 15; 90(9):935-44.
    View in: PubMed
    Score: 0.116
  19. Paradoxical functions of B7: CD28 costimulation in a MHC class II-mismatched cardiac transplant model. Am J Transplant. 2009 Dec; 9(12):2837-44.
    View in: PubMed
    Score: 0.108
  20. Immunoregulatory and lipid presentation pathways are upregulated in human face transplant rejection. J Clin Invest. 2021 04 15; 131(8).
    View in: PubMed
    Score: 0.060
  21. Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection. J Am Soc Nephrol. 2021 Mar 03.
    View in: PubMed
    Score: 0.059
  22. Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo. Sci Rep. 2020 08 28; 10(1):14249.
    View in: PubMed
    Score: 0.057
  23. Five-Year Follow-up after Face Transplantation. N Engl J Med. 2019 06 27; 380(26):2579-2581.
    View in: PubMed
    Score: 0.052
  24. Eponychial lesions following bilateral upper extremity vascular composite allotransplantation: a case report. Case Reports Plast Surg Hand Surg. 2018; 5(1):14-17.
    View in: PubMed
    Score: 0.048
  25. Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation. JCI Insight. 2017 11 02; 2(21).
    View in: PubMed
    Score: 0.047
  26. Integrated Kidney Exosome Analysis for the Detection of Kidney Transplant Rejection. ACS Nano. 2017 11 28; 11(11):11041-11046.
    View in: PubMed
    Score: 0.047
  27. Acute rejection in vascularized composite allotransplantation. Curr Opin Organ Transplant. 2014 Dec; 19(6):531-44.
    View in: PubMed
    Score: 0.038
  28. Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1018-25.
    View in: PubMed
    Score: 0.032
  29. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. J Immunol. 2011 Aug 01; 187(3):1113-9.
    View in: PubMed
    Score: 0.030
  30. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo. J Immunol. 2011 Aug 01; 187(3):1097-105.
    View in: PubMed
    Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.